Lapatinib EGFR inhibitors  

     

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultprogression or death (progression free survival PFS) death (overall survival)

advanced breast cancer (metastatic)  

Johnston (EGF30008) , 2009      NCTlapatinib + letrozoleletrozole alone HR positive Low risk of bias conclusive -29%-22%
Di Leo, 2008        NCTlapatinib + paclitaxelpaclitaxel alone 1st line Low risk of bias negative -10%-14%